Johnson and Johnson

How Johnson & Johnson Is Helping Over 40,000 Employees Exercise Their Ability to Vote in a Pandemic

By Liz Ozaist, Global Content Lab Editor-in-Chief, Johnson & Johnson
Summary: 

In an unprecedented year, you need to think of unprecedented ways to help your workforce feel supported—including on Election Day. The company's Chief Human Resources Officer shares why employees can take paid time off to vote this November.

Article

In an unprecedented year, you need to think of unprecedented ways to help your workforce feel supported—including on Election Day. The company's Chief Human Resources Officer shares why employees can take paid time off to vote this November.

Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19

Summary: 

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

Article

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

By Liz Ozaist, Global Content Lab Editor-in-Chief, Johnson & Johnson
Summary: 

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

Blog

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

The Science & Art of Goal Setting: Announcing Johnson & Johnson's New Climate Goals

by Paulette Frank, Worldwide Vice President, Environmental Health, Safety & Sustainability at Johnson & Johnson
Blog

I am so incredibly proud to have had the privilege to share Johnson & Johnson’s new climate goals during this Climate Week NYC 2020.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S
Press Release

NEW BRUNSWICK, N.J., September 28, 2020 – Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from the Company’s Phase 1/2a clinical study, which demonstrated that the safety profile and immunogenicity after a single vaccination were supportive of further development.

Johnson & Johnson Signs a Historic Pledge to Uphold the Integrity of the Scientific Process in Developing an Investigational COVID-19 Vaccine

In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
Article

Recently, Johnson & Johnson announced that we, alongside eight other companies working on investigational COVID-19 vaccines, are signing a #WeStandWithScience pledge committed to upholding the integrity of the scientific process as we work towards potential global regulatory filings and approvals of the first vaccines for COVID-19.

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog

Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.

Johnson & Johnson Recognized in the U.S. by ENERGY STAR as a “Partner Leader on Climate"

by Paulette Frank, Worldwide Vice President, Environmental Health, Safety & Sustainability at Johnson & Johnson
Blog

On this 50th Anniversary of Earth Day, I am proud to share that J&J is recognized in the U.S. by ENERGY STAR as a “Partner Leader on Climate”. We have had a long-standing commitment to the health of our environment because we understand that environmental health and human health are inextricably linked. we work to reduce our carbon footprint because we recognize that energy reduction and clean energy projects are good for the environment and for human health.

Could the Answer to Preventing Hospital-Acquired Pneumonia Be as Simple as Better Oral Care? This Nurse Thinks So

Summary: 

Some 157,000 patients are diagnosed with the condition each year. But trailblazing nurse Dian Baker has a straightforward yet innovative solution.

Article

Some 157,000 patients are diagnosed with the condition each year. But trailblazing nurse Dian Baker has a straightforward yet innovative solution.

“They Needed to Feel Loved”: How One Nurse Revolutionized Patient Care During the AIDS Crisis

By Cliff Morrison, as told to Brooke Porter Katz
Article

In the early 1980s, Cliff Morrison did what no other San Francisco General Hospital staff member had the guts to do: come up with a humane way to treat and care for AIDS patients. We sat down with him to learn more about the life-changing initiative—and how the legacy of Ward 5B lives on.

The human touch.

It seems like such a simple thing, but for San Francisco General Hospital nurses and doctors in the early 1980s, putting their hands on patients suffering from what was known at the time as “gay cancer” was unthinkable.

Pages

Subscribe to Johnson and Johnson